| 2025-02-12 | +220.1% | legal | SEC EDGAR | TIVC 8-K: 1.01, 3.02, 5.03, 7.01 (SEC Filing) |
| 2025-04-22 | +93.2% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2025-04-03 | +48.0% | legal | SEC EDGAR | TIVC 8-K: 3.02 and 8.01 (SEC Filing) |
| 2024-05-08 | -44.4% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2024-11-15 | -26.9% | earnings | Seeking Alpha | Tivic Health Systems GAAP EPS of -$0.23, revenue of $126K |
| 2025-11-14 | -26.8% | earnings | Seeking Alpha | Tivic Health Systems GAAP EPS of -$1.97, revenue of $0.15M |
| 2025-11-14 | -26.8% | legal | SEC EDGAR | TIVC 8-K: 2.02, 2.05, 7.01 (SEC Filing) |
| 2023-05-15 | -26.1% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-03-31 | -25.9% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-06 | -24.1% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2025-03-05 | -24.0% | news | Seeking Alpha | Tivic Health announces reverse stock split |
| 2026-04-15 | +20.5% | news | PR Newswire | Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th |
| 2026-04-15 | +20.5% | legal | Stock Titan | [EFFECT] Tivic Health Systems, Inc. SEC Filing - Stock Titan |
| 2026-04-15 | +20.5% | news | Stock Titan | Tivic pitches a faster radiation treatment concept to U.S. War Tech Watch - Stock Titan |
| 2026-04-15 | +20.5% | expansion | Stock Titan | Tumim may resell 956,222 Tivic shares; TIVC Purchase Agreement details (TIVC) - Stock Titan |
| 2025-11-15 | -20.4% | earnings | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Q3 2025 Earnings Call Prepared Remarks Transcript |
| 2024-08-13 | -19.9% | legal | SEC EDGAR | TIVC 8-K: 5.02, 5.07 (SEC Filing) |
| 2023-06-16 | +18.4% | legal | SEC EDGAR | TIVC 8-K: 5.07 and 8.01 (SEC Filing) |
| 2026-04-23 | +16.3% | earnings | PR Newswire | Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model |
| 2026-04-23 | +16.3% | news | Stock Titan | Tivic rebrands as Valion Bio, centering Entolimod and CDMO unit - Stock Titan |
| 2026-04-23 | +16.3% | news | Stock Titan | Valion Bio (Nasdaq: TIVC) pivots to late-stage biopharma with Entolimod and CDMO - Stock Titan |
| 2026-03-31 | +15.1% | news | ACCESS Newswire | Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod |
| 2026-03-31 | +15.1% | news | GlobeNewswire | Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live stream |
| 2026-03-31 | +15.1% | news | Stock Titan | Ukraine weighs Tivic radiation drug for emergency reserves - Stock Titan |
| 2026-03-26 | -15.0% | expansion | ACCESS Newswire | Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome |
| 2026-03-26 | -15.0% | news | Seeking Alpha | Tivic Health Systems reports FY25 results |
| 2026-03-24 | +14.9% | executive | ACCESS Newswire | Tivic Health CEO Letter to Shareholders |
| 2026-03-24 | +14.9% | news | Stock Titan | Tivic drops its sinus device to focus on radiation and cancer treatments - Stock Titan |
| 2024-11-12 | -14.4% | legal | Stock Titan | Tivic Health Secures Key European Patents for ClearUP Sinus Treatment Technology - Stock Titan |
| 2024-08-14 | -14.4% | earnings | Seeking Alpha | Tivic Health Systems GAAP EPS of -$0.32, revenue of $0.14M |
| 2024-08-14 | -14.4% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-11-14 | -14.3% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-04-14 | -13.3% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2025-11-13 | -13.1% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2025-08-08 | +12.8% | M&A | Seeking Alpha | Tivic Health registers 400K shares for resale linked to Statera License deal |
| 2026-03-27 | -12.0% | executive | ACCESS Newswire | Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference |
| 2024-03-25 | -11.9% | earnings | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Q4 2023 Earnings Call Transcript |
| 2024-03-25 | -11.9% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-12-11 | -11.6% | legal | SEC EDGAR | TIVC 8-K: 1.01, 1.02, 2.01, 2.03, 3.02, 3.03, 5.03, 7.01 (SEC Filing) |
| 2025-12-11 | -11.6% | news | Stock Titan | Tivic Health (Nasdaq: TIVC) adds CDMO unit to speed Entolimod manufacturing - Stock Titan |
| 2021-11-18 | -11.0% | legal | SEC EDGAR | TIVC 8-K: 1.01 and 7.01 (SEC Filing) |
| 2022-10-14 | +11.0% | legal | SEC EDGAR | TIVC 8-K: 1.01 and (SEC Filing) |
| 2024-11-14 | -10.5% | earnings | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Q3 2024 Earnings Call Transcript |
| 2024-11-14 | -10.5% | legal | SEC EDGAR | TIVC 8-K: 2.02 and 7.01 (SEC Filing) |
| 2025-11-18 | +10.2% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2024-05-22 | -9.9% | legal | SEC EDGAR | TIVC 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-07-25 | -9.8% | legal | SEC EDGAR | TIVC 8-K: 1.01 and (SEC Filing) |
| 2026-02-09 | +9.2% | legal | SEC EDGAR | TIVC 8-K: 1.01, 3.02 (SEC Filing) |
| 2022-12-01 | -8.9% | legal | SEC EDGAR | TIVC 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-04-25 | -8.9% | news | Stock Titan | TIVC Stock Price, News & Analysis | Tivic Health Systems - Stock Titan |
| 2026-03-13 | +8.4% | legal | SEC EDGAR | TIVC 8-K: 1.01 and (SEC Filing) |
| 2025-08-14 | +8.2% | earnings | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call Transcript |
| 2025-08-14 | +8.2% | earnings | Seeking Alpha | Tivic Health Systems GAAP EPS of -$2.19, revenue of $0.08M |
| 2025-08-14 | +8.2% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-02-24 | -8.2% | executive | Seeking Alpha | Former Statera CEO Michael Handley named Tivic Biopharma president |
| 2025-02-24 | -8.2% | legal | SEC EDGAR | TIVC 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-12-22 | -7.5% | legal | SEC EDGAR | TIVC 8-K: 5.02, 8.01 (SEC Filing) |
| 2026-03-20 | +7.5% | news | ACCESS Newswire | Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET |
| 2026-03-20 | +7.5% | news | TipRanks | Tivic Health Systems Receives Nasdaq Minimum Bid Price Notice - TipRanks |
| 2026-03-20 | +7.5% | news | Stock Titan | Tivic Health Systems (TIVC) faces Nasdaq minimum bid price deficiency and delisting risk - Stock Titan |
| 2026-03-20 | +7.5% | news | Stock Titan | March 25 webcast: Tivic to outline 2025 year-end results - Stock Titan |
| 2025-05-14 | +7.1% | legal | SEC EDGAR | TIVC 8-K: 1.01, 7.01 (SEC Filing) |
| 2024-09-13 | -7.1% | executive | Seeking Alpha | Tivic Health names Lisa Wolf as interim CFO |
| 2024-09-13 | -7.1% | legal | SEC EDGAR | TIVC 8-K: 1.01, 5.02, 7.01 (SEC Filing) |
| 2024-09-13 | -7.1% | executive | Stock Titan | Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer - Stock Titan |
| 2026-04-20 | -7.1% | news | Stock Titan | Tivic Health (TIVC) asks shareholders to OK 2.58M plan shares, Series C and $50M equity line - Stock Titan |
| 2025-04-10 | -6.7% | news | Seeking Alpha | Tivic Health Systems regains compliance with Nasdaq minimum bid price listing rule |
| 2025-04-10 | -6.7% | legal | SEC EDGAR | TIVC 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-01-26 | +6.4% | legal | SEC EDGAR | TIVC 8-K: 1.02 and 5.02 (SEC Filing) |
| 2024-05-16 | -6.3% | earnings | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Q1 2024 Earnings Call Transcript |
| 2026-01-12 | -5.9% | M&A | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Discusses Acquisition of Biomanufacturing Assets and Strategic Transformation Transcript |
| 2021-11-16 | -5.6% | news | Stock Titan | Latest TIVC News - Tivic Health Systems Rebrands as Valion Bio... - Stock Titan |
| 2025-08-20 | +5.6% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2022-10-25 | -5.5% | legal | SEC EDGAR | TIVC 8-K: 1.01 and (SEC Filing) |
| 2025-06-25 | -5.2% | legal | SEC EDGAR | TIVC 8-K: 1.01 and (SEC Filing) |
| 2025-08-15 | -5.2% | news | Seeking Alpha | Tivic Health signals exit from consumer health tech while advancing $19B+ immunotherapy market pipeline |
| 2022-09-09 | -5.1% | news | ChartMill | TIVC Stock Price, Quote & Chart | TIVIC HEALTH SYSTEMS INC (NASDAQ:TIVC) - ChartMill |
| 2022-08-15 | -5.0% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-17 | -4.9% | news | Seeking Alpha | Tivic Health files to sell 1.58M shares of common stock for holders |
| 2024-06-18 | -4.6% | legal | SEC EDGAR | TIVC 8-K: 5.02, 5.08, 7.01 (SEC Filing) |
| 2021-11-12 | +4.6% | earnings | MarketBeat | Tivic Health Systems (TIVC) Stock Price, News & Analysis $TIVC - MarketBeat |
| 2026-04-02 | -4.5% | news | Quiver Quantitative | TIVC | Tivic Health Systems, Inc. Insider Trading - Quiver Quantitative |
| 2026-04-02 | -4.5% | news | Stock Titan | Tivic Health (TIVC) director adds 19,000 shares in open-market buy - Stock Titan |
| 2022-02-05 | -4.5% | analyst | ChartMill | TIVC Forecast, Price Target & Analyst Ratings | TIVIC HEALTH SYSTEMS INC (NASDAQ:TIVC) - ChartMill |
| 2025-07-07 | +4.4% | legal | SEC EDGAR | TIVC 8-K: 5.02, 5.07 (SEC Filing) |
| 2023-07-11 | -4.3% | legal | SEC EDGAR | TIVC 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2024-08-15 | +4.1% | earnings | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Q2 2024 Earnings Call Transcript |
| 2024-05-15 | -4.0% | earnings | Seeking Alpha | Tivic Health Systems reports Q1 results |
| 2024-05-15 | -4.0% | legal | SEC EDGAR | TIVC 8-K: 2.01, 7.01 (SEC Filing) |
| 2023-07-19 | -3.8% | legal | SEC EDGAR | TIVC 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2023-05-01 | -3.8% | legal | SEC EDGAR | TIVC 8-K: 1.02, 5.02, 7.01 (SEC Filing) |
| 2022-01-01 | +3.8% | news | StockInvest.us | Tivic Health Systems Stock Price Forecast. Should You Buy TIVC? - StockInvest.us |
| 2025-06-04 | -3.6% | news | Intellectia AI | TIVC Forecast — Price Prediction for 2026. Should I Buy TIVC? - Intellectia AI |
| 2022-02-03 | +3.1% | news | ChartMill | TIVIC HEALTH SYSTEMS INC (TIVC) Fundamental Analysis & Valuation - ChartMill |
| 2024-03-28 | +2.7% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2023-04-06 | +2.6% | news | CoinCodex | Tivic Health Systems, Inc. (TIVC) Stock Forecast & Price Prediction 2026–2030 - CoinCodex |
| 2026-04-13 | -2.3% | news | Stock Titan | Tivic Health (NASDAQ: TIVC) sets $50M Tumim equity line and registers shares - Stock Titan |
| 2026-04-13 | -2.3% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Does Tivic (TIVC) Stock pay reliable income | Price at $0.92, Down 1.16% - Crowd Entry Signals - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-05-15 | -2.3% | earnings | Seeking Alpha | Tivic Health Systems GAAP EPS of -$2.52, revenue of $0.07M |
| 2025-05-15 | -2.3% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-21 | -2.1% | legal | Seeking Alpha | Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma |
| 2025-03-21 | -2.1% | earnings | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript |
| 2025-03-21 | -2.1% | earnings | Seeking Alpha | Tivic Health Systems GAAP EPS of -$19.68, revenue of $0.78M |
| 2025-03-21 | -2.1% | legal | SEC EDGAR | TIVC 8-K: 1.01, 2.02, 3.02, 7.01 (SEC Filing) |
| 2025-03-21 | -2.1% | news | Stock Titan | Tivic Health Slashes Losses by 30% While Expanding into Promising Biotech Markets - Stock Titan |
| 2026-03-11 | -2.0% | legal | SEC EDGAR | TIVC 8-K: 5.07 and 8.01 (SEC Filing) |
| 2025-05-02 | -2.0% | legal | SEC EDGAR | TIVC 8-K: 1.01, 3.02, 3.03, 5.03 (SEC Filing) |
| 2025-05-20 | +2.0% | legal | SEC EDGAR | TIVC 8-K: 5.08 and 8.01 (SEC Filing) |
| 2026-03-04 | +2.0% | executive | ACCESS Newswire | Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma |
| 2026-03-04 | +2.0% | legal | SEC EDGAR | TIVC 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-04 | +2.0% | expansion | Stock Titan | Biotech leader behind 17 drug launches now steering Tivic’s biopharma pivot - Stock Titan |
| 2022-11-14 | -1.8% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-25 | -1.8% | news | ACCESS Newswire | Tivic Reports Full Year 2025 Results |
| 2026-03-25 | -1.8% | news | Seeking Alpha | Tivic Health outlines $20B oncology market opportunity following strategic transformation |
| 2026-03-25 | -1.8% | earnings | Seeking Alpha | Tivic Health Systems, Inc. (TIVC) Q4 2025 Earnings Call Prepared Remarks Transcript |
| 2026-03-25 | -1.8% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-25 | -1.8% | news | Stock Titan | Tivic shuts consumer business, builds immunotherapy and CDMO arms - Stock Titan |
| 2026-03-25 | -1.8% | news | Stock Titan | Tivic Health (Nasdaq: TIVC) pivots to Entolimod immunotherapy and CDMO model - Stock Titan |
| 2025-10-15 | -1.8% | legal | SEC EDGAR | TIVC 8-K: 5.02 and (SEC Filing) |
| 2022-09-25 | -1.7% | news | StockInvest.us | Tivic Health Systems, Inc. Stock Data and Signals - TIVC - StockInvest.us |
| 2022-05-16 | -1.6% | legal | SEC EDGAR | TIVC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-08-27 | -1.5% | legal | SEC EDGAR | TIVC 8-K: 8.01 (SEC Filing) |
| 2024-05-13 | -1.5% | legal | SEC EDGAR | TIVC 8-K: 1.01, 8.01 (SEC Filing) |
| 2025-05-16 | -1.4% | news | Seeking Alpha | Tivic Health signals strategic transformation with $8.4M financing and biopharma focus amid market repositioning |
| 2025-05-16 | -1.4% | earnings | Seeking Alpha | Tivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call Transcript |
| 2025-05-13 | +1.3% | news | Seeking Alpha | Tivic expands VNS intellectual property portfolio |
| 2025-05-09 | -1.2% | news | Seeking Alpha | Tivic Health Systems files to sell 292,523 shares of common stock for holders |
| 2021-11-15 | +1.0% | legal | SEC EDGAR | TIVC 8-K: 1.01, 5.03, 8.01 (SEC Filing) |
| 2022-04-05 | +1.0% | legal | SEC EDGAR | TIVC 8-K: 1.01, 1.02, 5.02, 7.01 (SEC Filing) |
| 2024-05-30 | -1.0% | legal | SEC EDGAR | TIVC 8-K: 1.01, 1.02 (SEC Filing) |
| 2023-02-13 | +0.7% | legal | SEC EDGAR | TIVC 8-K: 1.01, 8.01 (SEC Filing) |
| 2023-08-09 | +0.6% | legal | SEC EDGAR | TIVC 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2023-08-14 | +0.6% | legal | SEC EDGAR | TIVC 8-K: 2.02, 5.07, 7.01 (SEC Filing) |
| 2026-04-21 | +0.5% | legal | Stock Titan | TIVC SEC Filings - Tivic Health Systems Inc 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2024-09-18 | +0.4% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2024-09-17 | -0.1% | legal | SEC EDGAR | TIVC 8-K: 8.01 and (SEC Filing) |
| 2026-04-24 | — | news | Sahm | Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening - Sahm |
| 2021-11-11 | — | news | TradingView | TIVC Stock Price and Chart — NASDAQ:TIVC - TradingView |